Human clinical trials of COVID-19 vaccine begins in November

If the vaccine works and is safe following the clinical trials, it is expected to be commercially marketed in mid-2022. (Photo: Ministry of Health)

Lieutenant General Pham Hoai Nam, Deputy Minister of National Defence made the announcement at a press briefing at Military Hospital 103 in Ha Noi.

However, Nam said for the safety reasons the hospital will evaluate the efficacy of the vaccine following its trials on monkeys before conducting the trial tests on human.

Vietnamese researchers of the Company for Vaccine and Biological Production No.1 (VABIOTECH) under the Ministry of Health have begun performing trials for the vaccine on 12 healthy macaca mulatta monkeys.

According to Prof. Dr. Nguyen Thu Van, former director of VABIOTECH, testing a COVID-19 vaccine on monkeys is just a step in the vaccine research process. Research units can choose to experiment on different animals such as mice, monkeys or rabbits.

This is a step forward for VABIOTECH, though it is still in the pre-clinical stage in laboratory, says Van.

She notes Vietnam is slow compared to the world in COVID-19 vaccine production, but the vaccine, after being licensed, will be used widely, clinical trials require great care. She points to the fact that the world has entered the clinical trial phase and problems have arisen in several countries.

“If laboratory results are good and satisfactory, we will have COVID-19 vaccine for use in mid-2022,” says Prof. Van.

Vietnam steps up health co-operation with the UK Acting Minister of Health Nguyen Thanh Long and British Ambassador Gareth Ward signed a memorandum of understanding on July 15 on cooperation to implement the ...

GAVI lauds Vietnam’s four ways to control COVID-19 GAVI, an international organization that works to improve access to new and underused vaccines for children in the world's poorest countries, has published an article ...

Vietnam gains initial success in developing COVID-19 vaccine A potential COVID-19 vaccine, Vietnamese scientists have tested on mice over the last ten days, showed initial success.